Unlike GAL-9, ACM did not induce significant increases in HAVCR2, the gene encoding TIM3, nor did it increase TIM3 surface expression on human B-ALL cells. Here, HAVCR2 is linked to precursor B-cell acute lymphoblastic leukemia.